Annals of neurology

Peer review at National Institutes of Health: small steps forward.

Annals of neurology

Johnston SC, Hauser SL

Scripts for science: a new wrinkle on academic ties with industry.

Annals of neurology

Hauser SL, Johnston SC

Investigator balkanization.

Annals of neurology

Johnston SC, Hauser SL

An election season prescription for healthcare.

Annals of neurology

Hauser SL, Johnston SC

Neurological disease on the global agenda.

Annals of neurology

Johnston SC, Hauser SL

That vexing problem of compensation.

Annals of neurology

Hauser SL, Johnston SC

Transformative research.

Annals of neurology

Johnston SC, Hauser SL

T2 clinical research: judgment day.

Annals of neurology

Claiborne Johnston S, Hauser SL

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.

Annals of neurology

Bar-Or A, Calabresi PA, Arnold D, Arnlod D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M, Sarkar N, Agarwal S, Smith CH

Pages